This is a routine 10b5-1 plan sale by a director — not a conviction-based signal. The 6,000-share amount is immaterial relative to Pande's holdings and the company's market cap. No bearish read-through; no trade action needed based on this filing alone.
Price Chart
Executive Summary
Director Atul Pande intends to sell 6,000 shares of Immunovant common stock, valued at approximately $201,720, via a Rule 10b5-1 plan exercised through stock options. The sale is a pre-planned, routine transaction by a director and represents a very small fraction of the company's $6.9B market cap.
Key Facts
- Selling insider: Atul Pande, Director of Immunovant
- Proposed sale: 6,000 shares of common stock
- Approximate value: $201,720 (at ~$33.62/share according to filing)
- Sale method: 10b5-1 trading plan via Morgan Stanley
- Shares acquired via exercise of stock options
- Prior sale under same plan: 6,000 shares on 05/20/2026 for $192,000
- Filing date: June 15, 2026
Financial Impact
$201,720 proposed sale value; less than 0.003% of $6.9B market cap
Risk Factors
- The filing is only an intent to sell — actual sale may not occur or may differ in size/timing
- Insider selling via 10b5-1 plans can sometimes mask opportunistic timing if the plan was set up near a peak
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-006090 |
| Document: 0001950047-26-006090-index.html | 0001950047-26-006090 |
| Document: 0001950047-26-006090.txt | 0001950047-26-006090 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 6, 2026 11w ago | 8-K | $39.74 $39.12 | ▲ +1.56% | ▲ +2.16% | $27.68 (+30.35%) |
Jul 24, 2026 13w ago | Insider Cluster | $40.09 $43.32 | ▲ +8.06% | ▲ +4.76% | $27.68 (−30.96%) |
Jun 26, 2026 17w ago | Insider Cluster | $38.51 $39.41 | ▲ +2.34% | ▲ +2.62% | $27.68 (−28.12%) |
Jun 26, 2026 17w ago | Insider Cluster | $38.51 $39.41 | ▲ +2.34% | ▲ +2.62% | $27.68 (−28.12%) |
Jun 26, 2026 17w ago | 144 | $38.51 $39.41 | ▲ +2.34% | ▲ +2.62% | $27.68 (−28.12%) |
Jun 26, 2026 17w ago | 144 | $38.51 $39.41 | ▲ +2.34% | ▲ +2.62% | $27.68 (−28.12%) |
Jun 15, 2026 18w ago | 144 | $33.61 $38.77 | ▲ +15.35% | ▲ +15.15% | $27.68 (−17.64%) |
May 28, 2026 21w ago | 144 | $33.30 $38.51 | ▲ +15.65% | ▲ +17.44% | $27.68 (−16.88%) |
May 20, 2026 22w ago | 8-K | $35.56 $35.34 | ▼ −0.62% | ▼ −1.36% | $27.68 (−22.16%) |
May 20, 2026 22w ago | Press Release | $35.56 $35.34 | ▼ −0.62% | ▼ −1.36% | $27.68 (−22.16%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers